Chronic loneliness linked to increased risk of stroke
Jun 28, 2024
Individuals with consistently high loneliness patterns over time had a significantly higher incident stroke risk.
Endocrine Society, June 1-4
Jun 20, 2024
The conference highlighted recent advances in the diagnosis and management of obesity, endocrine disorders, diabetes, and growth hormone and thyroid diseases.
Nonphysician-implemented multifaceted intervention beneficial in HTN
Jun 20, 2024
Significant reductions were seen in total cardiovascular disease and all-cause mortality for those aged 60 years and older; significant reductions also were seen for those younger than 60 years.
American Academy of Neurology, April 13-18
Apr 23, 2024
The annual meeting of the American Academy of Neurology was held this year from April 13 to 18 in Denver, drawing participants from around the world, including clinicians, academicians, allied health professionals,...
ACP: Recommendations developed for newer type 2 diabetes medications
Apr 22, 2024
A strong recommendation was given for the addition of an SGLT-2 or GLP-1 agonist to metformin, and lifestyle modifications.
Environmental Protection Agency finalizes stronger air quality standards
Feb 09, 2024
The agency estimates that the new standard will prevent up to 4,500 premature deaths in the first year of full enforcement.
Few adults know their heart health numbers
Feb 13, 2024
Less than 20% of US adults know their cholesterol or blood sugar levels.
Risk for CKD, CVD lower for adults with evidence of type 2 diabetes remission
Jan 26, 2024
Significantly lower risks of chronic kidney disease and composite cardiovascular disease measure were seen for those with any remission.
Artificial intelligence feasible for localizing acute stroke lesions
Mar 27, 2024
GPT-4 generated accurate neuroanatomical localization and detailed clinical reasoning based on processing of raw text from H&P.
Cannabis use linked to adverse cardiovascular outcomes
Feb 28, 2024
Proportionately lower log odds were seen for heart disease, heart attack, stroke and composite outcome for days of use between zero and 30 a month.